Glycogen storage disease type I other imaging findings
|
Glycogen storage disease type I Microchapters |
|
Differentiating Glycogen storage disease type I from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Glycogen storage disease type I other imaging findings On the Web |
|
American Roentgen Ray Society Images of Glycogen storage disease type I other imaging findings |
|
FDA on Glycogen storage disease type I other imaging findings |
|
CDC on Glycogen storage disease type I other imaging findings |
|
Glycogen storage disease type I other imaging findings in the news |
|
Blogs on Glycogen storage disease type I other imaging findings |
|
Directions to Hospitals Treating Glycogen storage disease type I |
|
Risk calculators and risk factors for Glycogen storage disease type I other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
Dual energy X-ray absorptiometry (DXA) may be helpful in the diagnosis of osteoporosis and/or osteopenia due to poor metabolic control in patients with glycogen storage disease type 1. Findings on an dual energy X-ray absorptiometry suggestive of osteoporosis and/or osteopenia in patients with glycogen storage disease type 1 include low bone mineral density (BMD).
Other Imaging Findings
Dual Energy X-ray Absorptiometry
- Glycogen storage disease type 1 with poor metabolic control develops osteoporosis and/or osteopenia which is associated with low bone mineral density (BMD).[1]
- Dual energy X-ray absorptiometry is used to diagnose low bone mineral density (BMD).
References
- ↑ Minarich LA, Kirpich A, Fiske LM, Weinstein DA (2012). "Bone mineral density in glycogen storage disease type Ia and Ib". Genet Med. doi:10.1038/gim.2012.36. PMC 3884026. PMID 22481133.